ClinVar Miner

Submissions for variant NM_000077.5(CDKN2A):c.299_303dup (p.Ala102fs)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV003387338 SCV004098329 pathogenic Hereditary cancer-predisposing syndrome 2023-08-17 criteria provided, single submitter clinical testing The c.299_303dupCCGGG pathogenic mutation, located in coding exon 2 of the CDKN2A gene, results from a duplication of CCGGG at nucleotide position 299, causing a translational frameshift with a predicted alternate stop codon (p.A102Pfs*46). This alteration occurs at the 3' terminus of theCDKN2A gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 55 amino acids of the protein. However, premature stop codons are typically deleterious in nature, the impacted region is critical for protein function and a significant portion of the protein is affected (Ambry internal data). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.